Advancing Breakthroughs in Neuroscience to Elevate Life
Fighting Disease So More “You” Shines Through
At Acadia, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We have developed therapies for the treatment of Rett syndrome and for hallucinations and delusions associated with Parkinson’s disease psychosis. Currently, our clinical-stage developments focus on addressing Prader-Willi syndrome, Alzheimer’s disease psychosis, and neuropsychiatric symptoms in CNS disorders.
We recently established operations in Canada and have filed for review with Health Canada our New Drug Submission for the treatment of Rett syndrome. Learn more here.
Our Purpose
We fight disease so more you shines through
Our Mission
Elevate Life
Our Values
We fight for patients to elevate life through science
We are driven by innovation to forge a healthy future
We are family, united through collaboration and diverse perspectives
We are determined, we break through barriers, we persevere
We take our work seriously, but not ourselves
Leading the Way in Rett Syndrome Therapy
Our commitment is unwavering towards creating a brighter future for individuals living with rare diseases and their families. Our efforts continue to focus on broadening access to essential therapies for families across the globe. In Canada, our treatment for Rett syndrome is currently under review.
Looking for more about Acadia?
Learn more about our company, research initiatives, community engagement, and career opportunities.
Contact Us
General Inquiries
[email protected]
Medical Information
[email protected]
Media Inquiries
[email protected]
Phone
+1 (437) 524-8811
Address
295 Robinson St., Suite 100
Oakville, Ontario L6J 1G7
